|
|
urogenital system development
|
GO:0001655 |
261 |
0.985
|
|
|
|
kidney development
|
GO:0001822 |
213 |
0.975
|
|
|
|
extracellular matrix organization
|
GO:0030198 |
147 |
0.929
|
|
|
|
renal system development
|
GO:0072001 |
225 |
0.887
|
|
|
|
renal system process
|
GO:0003014 |
48 |
0.852
|
|
|
|
negative regulation of growth
|
GO:0045926 |
99 |
0.824
|
|
|
|
blood circulation
|
GO:0008015 |
195 |
0.803
|
|
|
|
brown fat cell differentiation
|
GO:0050873 |
36 |
0.782
|
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
285 |
0.772
|
|
|
|
regulation of systemic arterial blood pressure
|
GO:0003073 |
61 |
0.771
|
|
|
|
kidney epithelium development
|
GO:0072073 |
121 |
0.765
|
|
|
|
sensory organ morphogenesis
|
GO:0090596 |
242 |
0.697
|
|
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.676
|
Fly |
|
|
skeletal muscle organ development
|
GO:0060538 |
163 |
0.647
|
Fly |
|
|
positive regulation of transcription from rna polymerase ii promoter involved in smooth muscle cell differentiation
|
GO:2000721 |
2 |
0.633
|
|
|
|
lymphocyte migration
|
GO:0072676 |
26 |
0.628
|
|
|
|
regulation of tube size
|
GO:0035150 |
57 |
0.599
|
|
|
|
nephron epithelium development
|
GO:0072009 |
92 |
0.588
|
|
|
|
telencephalon development
|
GO:0021537 |
186 |
0.573
|
|
|
|
renal tubule development
|
GO:0061326 |
87 |
0.569
|
Fly |
|
|
angiogenesis
|
GO:0001525 |
201 |
0.561
|
|
|
|
glial cell differentiation
|
GO:0010001 |
131 |
0.555
|
|
|
|
regulation of anatomical structure size
|
GO:0090066 |
178 |
0.553
|
|
|
|
development of primary sexual characteristics
|
GO:0045137 |
143 |
0.552
|
|
|
|
protein kinase c activating g protein coupled receptor signaling pathway
|
GO:0007205 |
4 |
0.542
|
|
|
|
morphogenesis of an epithelial sheet
|
GO:0002011 |
27 |
0.538
|
|
|
|
oviduct development
|
GO:0060066 |
3 |
0.537
|
Fly |
|
|
ureteric bud development
|
GO:0001657 |
94 |
0.536
|
|
|
|
response to amino acid
|
GO:0043200 |
37 |
0.535
|
Mouse |
|
|
mesonephric tubule development
|
GO:0072164 |
94 |
0.534
|
|
|
|
morphogenesis of a branching structure
|
GO:0001763 |
203 |
0.522
|
|
|
|
negative regulation of synapse assembly
|
GO:0051964 |
3 |
0.519
|
|
|
|
circulatory system process
|
GO:0003013 |
197 |
0.486
|
|
|
|
endocytosis
|
GO:0006897 |
168 |
0.475
|
|
|
|
ion transmembrane transport
|
GO:0034220 |
361 |
0.474
|
|
|
|
ras protein signal transduction
|
GO:0007265 |
77 |
0.473
|
|
|
|
metanephros development
|
GO:0001656 |
79 |
0.467
|
|
|
|
synaptic transmission
|
GO:0007268 |
329 |
0.463
|
|
|
|
regulation of systemic arterial blood pressure by hormone
|
GO:0001990 |
25 |
0.461
|
|
|
|
planar cell polarity pathway involved in cardiac right atrium morphogenesis
|
GO:0061349 |
2 |
0.459
|
|
|
|
odontogenesis
|
GO:0042476 |
78 |
0.447
|
|
|
|
germ cell development
|
GO:0007281 |
185 |
0.445
|
|
|
|
muscle cell differentiation
|
GO:0042692 |
261 |
0.439
|
Fly |
|
|
camera type eye development
|
GO:0043010 |
266 |
0.438
|
|
|
|
vasodilation by norepinephrine epinephrine involved in regulation of systemic arterial blood pressure
|
GO:0002025 |
3 |
0.438
|
|
|
|
purine nucleoside catabolic process
|
GO:0006152 |
205 |
0.436
|
|
|
|
morphogenesis of a branching epithelium
|
GO:0061138 |
193 |
0.436
|
|
|
|
cognition
|
GO:0050890 |
149 |
0.434
|
|
|
|
neuron projection guidance
|
GO:0097485 |
141 |
0.431
|
|
|
|
mammary gland morphogenesis
|
GO:0060443 |
54 |
0.429
|
|
|
|
regulation of systemic arterial blood pressure by renin angiotensin
|
GO:0003081 |
20 |
0.425
|
|
|
|
metanephric nephron epithelium development
|
GO:0072243 |
19 |
0.419
|
|
|
|
regulation of angiogenesis
|
GO:0045765 |
81 |
0.406
|
|
|
|
brain morphogenesis
|
GO:0048854 |
32 |
0.404
|
|
|
|
regulation of blood vessel size
|
GO:0050880 |
56 |
0.403
|
|
|
|
positive regulation of growth
|
GO:0045927 |
104 |
0.402
|
|
|
|
glomerulus development
|
GO:0032835 |
40 |
0.401
|
|
|
|
cation transport
|
GO:0006812 |
399 |
0.394
|
|
|
|
retina development in camera type eye
|
GO:0060041 |
119 |
0.375
|
|
|
|
rhombomere 5 development
|
GO:0021571 |
4 |
0.375
|
|
|
|
regulation of synaptic growth at neuromuscular junction
|
GO:0008582 |
4 |
0.373
|
|
|
|
renin angiotensin regulation of aldosterone production
|
GO:0002018 |
3 |
0.372
|
|
|
|
labyrinthine layer development
|
GO:0060711 |
49 |
0.369
|
|
|
|
axon guidance
|
GO:0007411 |
141 |
0.364
|
|
|
|
metanephric nephron development
|
GO:0072210 |
34 |
0.362
|
|
|
|
glomerular basement membrane development
|
GO:0032836 |
8 |
0.362
|
|
|
|
histamine induced gastric acid secretion
|
GO:0001697 |
1 |
0.360
|
|
|
|
planar cell polarity pathway involved in cardiac muscle tissue morphogenesis
|
GO:0061350 |
2 |
0.360
|
|
|
|
cellular response to amino acid stimulus
|
GO:0071230 |
29 |
0.357
|
Mouse |
|
|
positive regulation of cell migration
|
GO:0030335 |
109 |
0.353
|
|
|
|
chemotaxis
|
GO:0006935 |
247 |
0.352
|
|
|
|
purine ribonucleoside triphosphate metabolic process
|
GO:0009205 |
220 |
0.351
|
|
|
|
gland development
|
GO:0048732 |
330 |
0.350
|
|
|
|
defense response to other organism
|
GO:0098542 |
197 |
0.349
|
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
218 |
0.347
|
Human |
|
|
purine nucleotide catabolic process
|
GO:0006195 |
211 |
0.347
|
|
|
|
planar cell polarity pathway involved in pericardium morphogenesis
|
GO:0061354 |
2 |
0.346
|
|
|
|
fat cell differentiation
|
GO:0045444 |
160 |
0.345
|
|
|
|
trachea cartilage morphogenesis
|
GO:0060535 |
4 |
0.341
|
|
|
|
regulation of systemic arterial blood pressure mediated by a chemical signal
|
GO:0003044 |
33 |
0.341
|
|
|
|
negative regulation of systemic arterial blood pressure
|
GO:0003085 |
15 |
0.339
|
|
|
|
regulation of protein localization
|
GO:0032880 |
231 |
0.338
|
|
|
|
regulation of intrinsic apoptotic signaling pathway in response to osmotic stress by p53 class mediator
|
GO:1902238 |
1 |
0.337
|
|
|
|
microglia development
|
GO:0014005 |
2 |
0.336
|
|
|
|
bmp signaling pathway
|
GO:0030509 |
93 |
0.333
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.331
|
|
|
|
neuronal action potential
|
GO:0019228 |
54 |
0.331
|
|
|
|
morphogenesis of embryonic epithelium
|
GO:0016331 |
159 |
0.330
|
|
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
295 |
0.324
|
|
|
|
g protein coupled receptor signaling pathway
|
GO:0007186 |
243 |
0.322
|
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.322
|
Human |
|
|
planar cell polarity pathway involved in ventricular septum morphogenesis
|
GO:0061348 |
2 |
0.320
|
|
|
|
mesonephric tubule morphogenesis
|
GO:0072171 |
63 |
0.320
|
|
|
|
transmembrane receptor protein tyrosine kinase signaling pathway
|
GO:0007169 |
247 |
0.317
|
|
|
|
neural crest cell migration
|
GO:0001755 |
32 |
0.315
|
|
|
|
embryonic heart tube morphogenesis
|
GO:0003143 |
51 |
0.309
|
|
|
|
action potential
|
GO:0001508 |
78 |
0.309
|
|
|
|
embryonic organ morphogenesis
|
GO:0048562 |
276 |
0.304
|
|
|
|
forebrain development
|
GO:0030900 |
302 |
0.303
|
|
|
|
fertilization
|
GO:0009566 |
127 |
0.301
|
|
|
|
pericardium morphogenesis
|
GO:0003344 |
5 |
0.300
|
|
|
|
branching involved in salivary gland morphogenesis
|
GO:0060445 |
26 |
0.299
|
|
|
|
nerve development
|
GO:0021675 |
67 |
0.297
|
|
|
|
positive regulation of protein transport
|
GO:0051222 |
93 |
0.296
|
|
|
|
cellular response to acid chemical
|
GO:0071229 |
68 |
0.295
|
Mouse |
|
|
nephron tubule development
|
GO:0072080 |
84 |
0.295
|
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
97 |
0.291
|
|
|
|
kidney vasculature development
|
GO:0061440 |
15 |
0.290
|
|
|
|
digestive tract development
|
GO:0048565 |
190 |
0.288
|
Fly |
|
|
retina vasculature development in camera type eye
|
GO:0061298 |
17 |
0.283
|
|
|
|
primary neural tube formation
|
GO:0014020 |
95 |
0.280
|
|
|
|
positive regulation of neuron apoptotic process
|
GO:0043525 |
25 |
0.278
|
|
|
|
gastrin induced gastric acid secretion
|
GO:0001698 |
1 |
0.277
|
|
|
|
cellular response to growth factor stimulus
|
GO:0071363 |
197 |
0.277
|
Mouse |
|
|
multicellular organism growth
|
GO:0035264 |
161 |
0.271
|
|
|
|
wnt signaling pathway involved in forebrain neuroblast division
|
GO:0021874 |
2 |
0.265
|
|
|
|
ribonucleotide catabolic process
|
GO:0009261 |
208 |
0.262
|
|
|
|
nucleoside metabolic process
|
GO:0009116 |
246 |
0.261
|
|
|
|
response to organophosphorus
|
GO:0046683 |
22 |
0.260
|
|
|
|
glycosyl compound metabolic process
|
GO:1901657 |
246 |
0.259
|
|
|
|
cardiac chamber morphogenesis
|
GO:0003206 |
93 |
0.257
|
|
|
|
cell adhesion
|
GO:0007155 |
329 |
0.255
|
|
|
|
rho protein signal transduction
|
GO:0007266 |
32 |
0.254
|
|
|
|
leukocyte migration
|
GO:0050900 |
124 |
0.254
|
|
|
|
forebrain cell migration
|
GO:0021885 |
58 |
0.253
|
|
|
|
brain segmentation
|
GO:0035284 |
3 |
0.253
|
|
|
|
cell substrate adhesion
|
GO:0031589 |
130 |
0.251
|
|
|
|
rhombomere 3 morphogenesis
|
GO:0021658 |
2 |
0.248
|
|
|
|
oxidation reduction process
|
GO:0055114 |
342 |
0.247
|
|
|
|
gliogenesis
|
GO:0042063 |
141 |
0.247
|
|
|
|
regulation of branching involved in ureteric bud morphogenesis
|
GO:0090189 |
22 |
0.245
|
|
|
|
cell substrate junction assembly
|
GO:0007044 |
24 |
0.245
|
|
|
|
axonogenesis
|
GO:0007409 |
274 |
0.244
|
|
|
|
developmental maturation
|
GO:0021700 |
193 |
0.242
|
|
|
|
vascular process in circulatory system
|
GO:0003018 |
62 |
0.242
|
|
|
|
neural crest cell development
|
GO:0014032 |
48 |
0.239
|
|
|
|
planar cell polarity pathway involved in outflow tract morphogenesis
|
GO:0061347 |
2 |
0.239
|
|
|
|
regulation of bmp signaling pathway
|
GO:0030510 |
60 |
0.239
|
|
|
|
organic hydroxy compound metabolic process
|
GO:1901615 |
203 |
0.232
|
|
|
|
branching involved in ureteric bud morphogenesis
|
GO:0001658 |
56 |
0.232
|
|
|
|
neuron apoptotic process
|
GO:0051402 |
142 |
0.231
|
|
|
|
regulation of membrane potential
|
GO:0042391 |
192 |
0.231
|
|
|
|
purine nucleotide metabolic process
|
GO:0006163 |
302 |
0.231
|
|
|
|
organonitrogen compound catabolic process
|
GO:1901565 |
264 |
0.230
|
|
|
|
vasodilation
|
GO:0042311 |
28 |
0.230
|
|
|
|
second messenger mediated signaling
|
GO:0019932 |
73 |
0.230
|
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.227
|
|
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
205 |
0.225
|
|
|
|
kidney morphogenesis
|
GO:0060993 |
83 |
0.225
|
|
|
|
peptidyl tyrosine modification
|
GO:0018212 |
145 |
0.223
|
|
|
|
mesonephros development
|
GO:0001823 |
97 |
0.218
|
|
|
|
respiratory system development
|
GO:0060541 |
190 |
0.217
|
|
|
|
regulation of hydrolase activity
|
GO:0051336 |
246 |
0.216
|
Human |
|
|
tertiary branching involved in mammary gland duct morphogenesis
|
GO:0060748 |
3 |
0.216
|
|
|
|
odontogenesis of dentin containing tooth
|
GO:0042475 |
66 |
0.215
|
|
|
|
regulation of vasoconstriction
|
GO:0019229 |
14 |
0.215
|
|
|
|
transmission of nerve impulse
|
GO:0019226 |
76 |
0.213
|
|
|
|
regulation of blood pressure
|
GO:0008217 |
93 |
0.209
|
|
|
|
mesenchyme development
|
GO:0060485 |
152 |
0.209
|
|
|
|
nephron development
|
GO:0072006 |
109 |
0.209
|
|
|
|
regulation of neuron apoptotic process
|
GO:0043523 |
122 |
0.208
|
|
|
|
nucleotide catabolic process
|
GO:0009166 |
217 |
0.208
|
|
|
|
polarity specification of proximal distal axis
|
GO:0010085 |
2 |
0.206
|
|
|
|
microglia differentiation
|
GO:0014004 |
2 |
0.205
|
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.205
|
|
|
|
extracellular structure organization
|
GO:0043062 |
148 |
0.205
|
|
|
|
nitrogen compound transport
|
GO:0071705 |
271 |
0.205
|
|
|
|
heart morphogenesis
|
GO:0003007 |
178 |
0.204
|
|
|
|
response to decreased oxygen levels
|
GO:0036293 |
59 |
0.203
|
|
|
|
positive regulation of mesonephros development
|
GO:0061213 |
20 |
0.202
|
|
|
|
purine ribonucleotide metabolic process
|
GO:0009150 |
290 |
0.201
|
|
|
|
eye photoreceptor cell differentiation
|
GO:0001754 |
41 |
0.200
|
|
|
|
positive regulation of t cell activation
|
GO:0050870 |
101 |
0.196
|
|
|
|
intracellular protein transport
|
GO:0006886 |
204 |
0.193
|
|
|
|
metanephric glomerular epithelium development
|
GO:0072244 |
3 |
0.193
|
|
|
|
regulation of defense response
|
GO:0031347 |
233 |
0.193
|
|
|
|
memory
|
GO:0007613 |
58 |
0.193
|
|
|
|
regulation of renal output by angiotensin
|
GO:0002019 |
2 |
0.191
|
|
|
|
neural tube formation
|
GO:0001841 |
108 |
0.191
|
|
|
|
protein maturation
|
GO:0051604 |
176 |
0.191
|
Human |
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.190
|
Mouse |
|
|
epithelial tube morphogenesis
|
GO:0060562 |
303 |
0.189
|
Fly |
|
|
retinal blood vessel morphogenesis
|
GO:0061304 |
3 |
0.188
|
|
|
|
renal filtration cell differentiation
|
GO:0061318 |
10 |
0.187
|
|
|
|
telencephalon cell migration
|
GO:0022029 |
55 |
0.187
|
|
|
|
renal system process involved in regulation of systemic arterial blood pressure
|
GO:0003071 |
15 |
0.187
|
|
|
|
metanephric glomerular mesangium development
|
GO:0072223 |
3 |
0.186
|
|
|
|
sodium ion transmembrane transport
|
GO:0035725 |
49 |
0.186
|
|
|
|
positive regulation of cell activation
|
GO:0050867 |
158 |
0.186
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.185
|
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.185
|
|
|
|
regulation of renal sodium excretion
|
GO:0035813 |
3 |
0.182
|
|
|
|
multicellular organismal signaling
|
GO:0035637 |
91 |
0.182
|
|
|
|
pericardium development
|
GO:0060039 |
16 |
0.180
|
|
|
|
ribonucleotide metabolic process
|
GO:0009259 |
291 |
0.180
|
|
|
|
neutrophil chemotaxis
|
GO:0030593 |
36 |
0.179
|
|
|
|
negative regulation of metanephric glomerulus development
|
GO:0072299 |
1 |
0.178
|
|
|
|
dephosphorylation
|
GO:0016311 |
129 |
0.177
|
|
|
|
striated muscle tissue development
|
GO:0014706 |
293 |
0.177
|
Fly |
|
|
macromolecule catabolic process
|
GO:0009057 |
281 |
0.176
|
|
|
|
sodium ion transport
|
GO:0006814 |
73 |
0.175
|
|
|
|
regulation of sodium ion transmembrane transport
|
GO:1902305 |
9 |
0.174
|
|
|
|
intrinsic apoptotic signaling pathway in response to osmotic stress by p53 class mediator
|
GO:1990127 |
1 |
0.174
|
|
|
|
positive regulation of blood pressure
|
GO:0045777 |
21 |
0.173
|
|
|
|
nephron epithelium morphogenesis
|
GO:0072088 |
68 |
0.173
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.172
|
|
|
|
glycosyl compound catabolic process
|
GO:1901658 |
206 |
0.170
|
|
|
|
epithelial cell morphogenesis
|
GO:0003382 |
41 |
0.170
|
|
|
|
labyrinthine layer morphogenesis
|
GO:0060713 |
21 |
0.166
|
|
|
|
aromatic compound catabolic process
|
GO:0019439 |
286 |
0.166
|
|
|
|
positive regulation of cytosolic calcium ion concentration involved in phospholipase c activating g protein coupled signaling pathway
|
GO:0051482 |
4 |
0.166
|
|
|
|
metanephric loop of henle development
|
GO:0072236 |
4 |
0.164
|
|
|
|
positive regulation of mitotic cell cycle embryonic
|
GO:0045977 |
2 |
0.163
|
|
|
|
cell growth
|
GO:0016049 |
130 |
0.162
|
|
|
|
retina vasculature morphogenesis in camera type eye
|
GO:0061299 |
10 |
0.160
|
|
|
|
cardiac right atrium morphogenesis
|
GO:0003213 |
3 |
0.160
|
|
|
|
neuron projection extension
|
GO:1990138 |
64 |
0.160
|
|
|
|
cardiac muscle tissue development
|
GO:0048738 |
130 |
0.159
|
Fly |
|
|
positive regulation of endothelial cell chemotaxis
|
GO:2001028 |
1 |
0.158
|
|
|
|
determination of left right symmetry
|
GO:0007368 |
80 |
0.157
|
|
|
|
appendage morphogenesis
|
GO:0035107 |
149 |
0.156
|
|
|
|
parasympathetic nervous system development
|
GO:0048486 |
19 |
0.156
|
|
|
|
ear morphogenesis
|
GO:0042471 |
118 |
0.155
|
|
|
|
central nervous system segmentation
|
GO:0035283 |
3 |
0.154
|
|
|
|
multicellular organismal homeostasis
|
GO:0048871 |
164 |
0.154
|
|
|
|
positive regulation of branching involved in ureteric bud morphogenesis
|
GO:0090190 |
18 |
0.154
|
|
|
|
regulation of cell motility
|
GO:2000145 |
236 |
0.153
|
|
|
|
immune effector process
|
GO:0002252 |
321 |
0.153
|
|
|
|
neuron migration
|
GO:0001764 |
122 |
0.152
|
|
|
|
metanephric glomerulus vasculature development
|
GO:0072239 |
7 |
0.151
|
|
|
|
skeletal system morphogenesis
|
GO:0048705 |
203 |
0.151
|
|
|
|
positive regulation of heart rate by epinephrine norepinephrine
|
GO:0001996 |
4 |
0.151
|
|
|
|
response to organic cyclic compound
|
GO:0014070 |
198 |
0.151
|
|
|
|
regulation of ossification
|
GO:0030278 |
112 |
0.151
|
|
|
|
inorganic ion transmembrane transport
|
GO:0098660 |
234 |
0.150
|
|
|
|
response to extracellular stimulus
|
GO:0009991 |
127 |
0.149
|
|
|
|
mammary gland duct morphogenesis
|
GO:0060603 |
38 |
0.149
|
|
|
|
renal vesicle morphogenesis
|
GO:0072077 |
15 |
0.149
|
|
|
|
regulation of transcription from rna polymerase ii promoter in response to hypoxia
|
GO:0061418 |
2 |
0.148
|
|
|
|
regulation of blood circulation
|
GO:1903522 |
93 |
0.147
|
|
|
|
negative regulation of intracellular signal transduction
|
GO:1902532 |
167 |
0.147
|
|
|
|
rhombomere 3 development
|
GO:0021569 |
4 |
0.147
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.146
|
|
|
|
positive regulation of lymphocyte activation
|
GO:0051251 |
140 |
0.146
|
|
|
|
negative regulation of sterol transport
|
GO:0032372 |
4 |
0.146
|
|
|
|
purine nucleoside metabolic process
|
GO:0042278 |
241 |
0.145
|
|
|
|
positive regulation of metanephric glomerulus development
|
GO:0072300 |
4 |
0.144
|
|
|
|
mesoderm development
|
GO:0007498 |
100 |
0.143
|
|
|
|
embryonic epithelial tube formation
|
GO:0001838 |
130 |
0.143
|
|
|
|
embryonic appendage morphogenesis
|
GO:0035113 |
126 |
0.143
|
|
|
|
sensory perception
|
GO:0007600 |
245 |
0.143
|
|
|
|
visual perception
|
GO:0007601 |
52 |
0.142
|
|
|
|
peptide hormone processing
|
GO:0016486 |
9 |
0.142
|
|
|
|
anatomical structure arrangement
|
GO:0048532 |
20 |
0.141
|
|
|
|
response to growth factor
|
GO:0070848 |
198 |
0.140
|
Mouse |
|
|
metanephric part of ureteric bud development
|
GO:0035502 |
2 |
0.140
|
|
|
|
canonical wnt signaling pathway involved in regulation of cell proliferation
|
GO:0044340 |
3 |
0.140
|
|
|
|
phospholipase c activating serotonin receptor signaling pathway
|
GO:0007208 |
1 |
0.139
|
|
|
|
cardiac muscle cell differentiation
|
GO:0055007 |
69 |
0.139
|
Fly |
|
|
response to increased oxygen levels
|
GO:0036296 |
2 |
0.139
|
|
|
|
inorganic cation transmembrane transport
|
GO:0098662 |
207 |
0.139
|
|
|
|
generation of precursor metabolites and energy
|
GO:0006091 |
103 |
0.139
|
|
|
|
embryonic placenta morphogenesis
|
GO:0060669 |
25 |
0.138
|
|
|
|
regulation of dna templated transcription in response to stress
|
GO:0043620 |
9 |
0.136
|
|
|
|
establishment of protein localization to plasma membrane
|
GO:0090002 |
34 |
0.136
|
|
|
|
inflammatory response
|
GO:0006954 |
244 |
0.136
|
|
|
|
multi multicellular organism process
|
GO:0044706 |
109 |
0.135
|
|
|
|
platelet derived growth factor receptor signaling pathway
|
GO:0048008 |
32 |
0.135
|
|
|
|
hair cycle
|
GO:0042633 |
90 |
0.134
|
|
|
|
neural crest cell differentiation
|
GO:0014033 |
54 |
0.134
|
|
|
|
regulation of cell migration
|
GO:0030334 |
219 |
0.134
|
|
|
|
monoamine transport
|
GO:0015844 |
33 |
0.134
|
|
|
|
metanephric glomerular endothelium development
|
GO:0072264 |
1 |
0.134
|
|
|
|
negative regulation of phosphate metabolic process
|
GO:0045936 |
184 |
0.134
|
|
|
|
peptide secretion
|
GO:0002790 |
114 |
0.133
|
|
|
|
salivary gland development
|
GO:0007431 |
37 |
0.133
|
|
|
|
cellular response to camp
|
GO:0071320 |
11 |
0.133
|
|
|
|
somitogenesis
|
GO:0001756 |
69 |
0.133
|
|
|
|
negative regulation of cell motility
|
GO:2000146 |
61 |
0.132
|
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.131
|
|
|
|
plasma membrane organization
|
GO:0007009 |
90 |
0.131
|
|
|
|
positive regulation of cell death
|
GO:0010942 |
224 |
0.131
|
Human |
|
|
formation of radial glial scaffolds
|
GO:0021943 |
4 |
0.131
|
|
|
|
regulation of cellular component biogenesis
|
GO:0044087 |
181 |
0.131
|
|
|
|
regulation of kinase activity
|
GO:0043549 |
249 |
0.130
|
|
|
|
t cell differentiation
|
GO:0030217 |
174 |
0.130
|
|
|
|
regulation of metal ion transport
|
GO:0010959 |
106 |
0.128
|
|
|
|
positive regulation of protein secretion
|
GO:0050714 |
52 |
0.128
|
|
|
|
ribonucleoside metabolic process
|
GO:0009119 |
245 |
0.128
|
|
|
|
negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress by p53 class mediator
|
GO:1902239 |
1 |
0.128
|
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.128
|
|
|
|
regulation of transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0090092 |
112 |
0.127
|
|
|
|
cerebral cortex cell migration
|
GO:0021795 |
44 |
0.127
|
|
|
|
cation transmembrane transport
|
GO:0098655 |
266 |
0.127
|
|
|
|
response to molecule of bacterial origin
|
GO:0002237 |
143 |
0.126
|
|
|
|
planar cell polarity pathway involved in heart morphogenesis
|
GO:0061346 |
3 |
0.125
|
|
|
|
cellular nitrogen compound catabolic process
|
GO:0044270 |
280 |
0.124
|
|
|
|
extrinsic apoptotic signaling pathway
|
GO:0097191 |
126 |
0.124
|
|
|
|
positive regulation of nervous system development
|
GO:0051962 |
221 |
0.124
|
|
|
|
embryonic placenta development
|
GO:0001892 |
98 |
0.124
|
|
|
|
negative regulation of smooth muscle cell apoptotic process
|
GO:0034392 |
1 |
0.122
|
|
|
|
positive regulation of protein kinase activity
|
GO:0045860 |
144 |
0.122
|
|
|
|
ribonucleoside triphosphate catabolic process
|
GO:0009203 |
199 |
0.122
|
|
|
|
learning or memory
|
GO:0007611 |
148 |
0.122
|
|
|
|
maternal process involved in female pregnancy
|
GO:0060135 |
32 |
0.121
|
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
241 |
0.121
|
|
|
|
adrenal cortex formation
|
GO:0035802 |
2 |
0.121
|
|
|
|
mesonephric epithelium development
|
GO:0072163 |
94 |
0.120
|
|
|
|
receptor mediated endocytosis
|
GO:0006898 |
51 |
0.120
|
|
|
|
regulation of protein transport
|
GO:0051223 |
163 |
0.120
|
|
|
|
pronephric nephron development
|
GO:0039019 |
1 |
0.120
|
|
|
|
negative regulation of phosphorylation
|
GO:0042326 |
166 |
0.120
|
|
|
|
ubiquitin dependent protein catabolic process
|
GO:0006511 |
129 |
0.120
|
|
|
|
forebrain generation of neurons
|
GO:0021872 |
63 |
0.118
|
|
|
|
cytokine secretion
|
GO:0050663 |
72 |
0.118
|
|
|
|
mesenchymal cell apoptotic process involved in metanephros development
|
GO:1900200 |
4 |
0.117
|
|
|
|
connective tissue development
|
GO:0061448 |
179 |
0.117
|
|
|
|
negative regulation of cellular component organization
|
GO:0051129 |
194 |
0.117
|
|
|
|
regulation of angiotensin metabolic process
|
GO:0060177 |
4 |
0.116
|
|
|
|
anion transmembrane transport
|
GO:0098656 |
71 |
0.116
|
|
|
|
positive regulation of vasoconstriction
|
GO:0045907 |
4 |
0.116
|
|
|
|
axis elongation involved in somitogenesis
|
GO:0090245 |
4 |
0.115
|
|
|
|
paraxial mesodermal cell fate commitment
|
GO:0048343 |
2 |
0.115
|
|
|
|
vasoconstriction
|
GO:0042310 |
27 |
0.115
|
|
|
|
ear development
|
GO:0043583 |
200 |
0.114
|
|
|
|
response to monosaccharide
|
GO:0034284 |
67 |
0.114
|
|
|
|
parental behavior
|
GO:0060746 |
11 |
0.114
|
|
|
|
cell cell adhesion
|
GO:0098609 |
41 |
0.113
|
|
|
|
operant conditioning
|
GO:0035106 |
2 |
0.112
|
|
|
|
metanephric glomerular mesangial cell proliferation involved in metanephros development
|
GO:0072262 |
3 |
0.112
|
|
|
|
metanephric epithelium development
|
GO:0072207 |
21 |
0.112
|
|
|
|
regulation of system process
|
GO:0044057 |
200 |
0.112
|
|
|
|
g protein coupled receptor internalization
|
GO:0002031 |
3 |
0.112
|
|
|
|
purine ribonucleoside triphosphate catabolic process
|
GO:0009207 |
199 |
0.112
|
|
|
|
regulation of mesonephros development
|
GO:0061217 |
24 |
0.112
|
|
|
|
glomerular visceral epithelial cell development
|
GO:0072015 |
6 |
0.111
|
|
|
|
establishment of protein localization to organelle
|
GO:0072594 |
118 |
0.110
|
|
|
|
thyroid stimulating hormone secreting cell differentiation
|
GO:0060129 |
4 |
0.109
|
|
|
|
regulation of sodium ion transmembrane transporter activity
|
GO:2000649 |
9 |
0.109
|
|
|
|
anion transport
|
GO:0006820 |
177 |
0.109
|
|
|
|
calcium mediated signaling
|
GO:0019722 |
46 |
0.108
|
|
|
|
negative regulation of prostatic bud formation
|
GO:0060686 |
4 |
0.108
|
|
|
|
regulation of neuron death
|
GO:1901214 |
134 |
0.108
|
|
|
|
transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0007178 |
194 |
0.108
|
|
|
|
tube formation
|
GO:0035148 |
140 |
0.108
|
|
|
|
gonad development
|
GO:0008406 |
141 |
0.107
|
|
|
|
canonical wnt signaling pathway
|
GO:0060070 |
130 |
0.107
|
|
|
|
calcium ion transport
|
GO:0006816 |
159 |
0.107
|
|
|
|
intrinsic apoptotic signaling pathway in response to osmotic stress
|
GO:0008627 |
2 |
0.106
|
|
|
|
skeletal system development
|
GO:0001501 |
356 |
0.106
|
|
|
|
paraxial mesodermal cell differentiation
|
GO:0048342 |
2 |
0.106
|
|
|
|
cellular response to oxidative stress
|
GO:0034599 |
76 |
0.105
|
|
|
|
corticotropin releasing hormone secretion
|
GO:0043396 |
2 |
0.105
|
|
|
|
cell differentiation involved in kidney development
|
GO:0061005 |
33 |
0.105
|
|
|
|
ribonucleoside catabolic process
|
GO:0042454 |
206 |
0.105
|
|
|
|
mesonephric duct formation
|
GO:0072181 |
2 |
0.105
|
|
|
|
carbohydrate transport
|
GO:0008643 |
62 |
0.105
|
|
|
|
ossification
|
GO:0001503 |
216 |
0.104
|
|
|
|
cellular response to extracellular stimulus
|
GO:0031668 |
81 |
0.104
|
|
|
|
cellular response to lipid
|
GO:0071396 |
145 |
0.104
|
|
|
|
mesendoderm development
|
GO:0048382 |
3 |
0.102
|
|
|
|
organic hydroxy compound transport
|
GO:0015850 |
93 |
0.102
|
|
|
|
establishment of planar polarity involved in neural tube closure
|
GO:0090177 |
15 |
0.101
|
|
|
|
drug catabolic process
|
GO:0042737 |
2 |
0.100
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.100
|
|
|
|
cellular response to temperature stimulus
|
GO:0071502 |
2 |
0.100
|
|
|
|
regulation of osteoblast proliferation
|
GO:0033688 |
15 |
0.099
|
|
|
|
cellular response to external stimulus
|
GO:0071496 |
88 |
0.098
|
|
|
|
bud outgrowth involved in lung branching
|
GO:0060447 |
2 |
0.098
|
|
|
|
development of primary female sexual characteristics
|
GO:0046545 |
73 |
0.098
|
|
|
|
cell maturation
|
GO:0048469 |
127 |
0.098
|
|
|
|
water transport
|
GO:0006833 |
12 |
0.098
|
|
|
|
morphogenesis of a polarized epithelium
|
GO:0001738 |
37 |
0.098
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.097
|
|
|
|
regulation of sequence specific dna binding transcription factor activity
|
GO:0051090 |
106 |
0.097
|
|
|
|
regulation of intrinsic apoptotic signaling pathway in response to osmotic stress
|
GO:1902218 |
1 |
0.097
|
|
|
|
exploration behavior
|
GO:0035640 |
21 |
0.096
|
|
|
|
response to hypoxia
|
GO:0001666 |
58 |
0.096
|
|
|
|
stem cell proliferation
|
GO:0072089 |
117 |
0.095
|
|
|
|
t cell differentiation in thymus
|
GO:0033077 |
77 |
0.095
|
|
|
|
non canonical wnt signaling pathway involved in heart development
|
GO:0061341 |
3 |
0.095
|
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.094
|
|
|
|
neuromuscular process
|
GO:0050905 |
99 |
0.094
|
|
|
|
regulation of sodium ion transport
|
GO:0002028 |
29 |
0.094
|
|
|
|
regulation of purine nucleotide metabolic process
|
GO:1900542 |
169 |
0.094
|
|
|
|
neurotransmitter transport
|
GO:0006836 |
76 |
0.094
|
|
|
|
digestive tract morphogenesis
|
GO:0048546 |
147 |
0.094
|
Fly |
|
|
oogenesis
|
GO:0048477 |
56 |
0.094
|
|
|
|
nucleoside monophosphate metabolic process
|
GO:0009123 |
85 |
0.093
|
|
|
|
positive regulation of the force of heart contraction by chemical signal
|
GO:0003099 |
3 |
0.093
|
|
|
|
epithelial tube formation
|
GO:0072175 |
130 |
0.091
|
|
|
|
negative regulation of nervous system development
|
GO:0051961 |
156 |
0.091
|
|
|
|
cellular response to prostaglandin d stimulus
|
GO:0071799 |
1 |
0.091
|
|
|
|
cell matrix adhesion
|
GO:0007160 |
68 |
0.090
|
|
|
|
positive regulation of cell motility
|
GO:2000147 |
116 |
0.090
|
|
|
|
regulation of ras protein signal transduction
|
GO:0046578 |
114 |
0.090
|
|
|
|
metanephric proximal straight tubule development
|
GO:0072230 |
1 |
0.090
|
|
|
|
myeloid dendritic cell activation
|
GO:0001773 |
25 |
0.089
|
|
|
|
protein catabolic process
|
GO:0030163 |
221 |
0.089
|
|
|
|
bone resorption
|
GO:0045453 |
38 |
0.089
|
|
|
|
male gamete generation
|
GO:0048232 |
285 |
0.089
|
|
|
|
negative regulation of smooth muscle cell migration
|
GO:0014912 |
2 |
0.089
|
|
|
|
drug metabolic process
|
GO:0017144 |
4 |
0.089
|
|
|
|
nephron morphogenesis
|
GO:0072028 |
69 |
0.089
|
|
|
|
purine nucleoside triphosphate metabolic process
|
GO:0009144 |
226 |
0.089
|
|
|
|
pallium development
|
GO:0021543 |
120 |
0.089
|
|
|
|
myelination
|
GO:0042552 |
74 |
0.089
|
|
|
|
regulation of ureteric bud formation
|
GO:0072106 |
3 |
0.088
|
|
|
|
sensitization
|
GO:0046960 |
2 |
0.088
|
|
|
|
axon ensheathment
|
GO:0008366 |
76 |
0.088
|
|
|
|
cerebral cortex development
|
GO:0021987 |
86 |
0.088
|
|
|
|
transmembrane transport
|
GO:0055085 |
412 |
0.087
|
|
|
|
male gonad development
|
GO:0008584 |
88 |
0.087
|
|
|
|
placenta development
|
GO:0001890 |
140 |
0.087
|
|
|
|
olfactory lobe development
|
GO:0021988 |
32 |
0.086
|
|
|
|
renal sodium excretion
|
GO:0035812 |
3 |
0.086
|
|
|
|
regulation of ion transmembrane transport
|
GO:0034765 |
119 |
0.086
|
|
|
|
cell junction organization
|
GO:0034330 |
77 |
0.086
|
|
|
|
regulation of systemic arterial blood pressure by circulatory renin angiotensin
|
GO:0001991 |
13 |
0.085
|
|
|
|
cell proliferation in hindbrain
|
GO:0021534 |
10 |
0.085
|
|
|
|
negative regulation of transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0090101 |
61 |
0.085
|
|
|
|
regulation of hormone levels
|
GO:0010817 |
211 |
0.085
|
|
|
|
t cell proliferation
|
GO:0042098 |
120 |
0.084
|
|
|
|
glomerular epithelium development
|
GO:0072010 |
11 |
0.084
|
|
|
|
adrenal cortex development
|
GO:0035801 |
2 |
0.084
|
|
|
|
lung morphogenesis
|
GO:0060425 |
50 |
0.083
|
|
|
|
negative regulation of platelet derived growth factor receptor signaling pathway
|
GO:0010642 |
7 |
0.083
|
|
|
|
male sex differentiation
|
GO:0046661 |
109 |
0.083
|
|
|
|
positive regulation of purine nucleotide catabolic process
|
GO:0033123 |
88 |
0.083
|
|
|
|
endocrine process
|
GO:0050886 |
39 |
0.082
|
|
|
|
response to camp
|
GO:0051591 |
14 |
0.082
|
|
|
|
potassium ion transport
|
GO:0006813 |
52 |
0.082
|
|
|
|
stem cell development
|
GO:0048864 |
219 |
0.082
|
|
|
|
positive regulation of the force of heart contraction by epinephrine norepinephrine
|
GO:0001997 |
3 |
0.082
|
|
|
|
pituitary gland development
|
GO:0021983 |
38 |
0.082
|
|
|
|
cranial nerve development
|
GO:0021545 |
41 |
0.082
|
|
|
|
cerebellar granule cell precursor proliferation
|
GO:0021930 |
10 |
0.081
|
|
|
|
response to oxygen levels
|
GO:0070482 |
62 |
0.081
|
|
|
|
dendritic spine maintenance
|
GO:0097062 |
4 |
0.081
|
|
|
|
muscle system process
|
GO:0003012 |
141 |
0.081
|
|
|
|
embryonic skeletal system development
|
GO:0048706 |
120 |
0.081
|
|
|
|
amino acid transmembrane transport
|
GO:0003333 |
37 |
0.080
|
|
|
|
regulation of cell activation
|
GO:0050865 |
289 |
0.080
|
|
|
|
adult behavior
|
GO:0030534 |
135 |
0.079
|
|
|
|
regulation of cellular response to growth factor stimulus
|
GO:0090287 |
82 |
0.079
|
|
|
|
regulation of fibroblast growth factor production
|
GO:0090270 |
4 |
0.079
|
|
|
|
nuclear transport
|
GO:0051169 |
139 |
0.079
|
|
|
|
neural tube development
|
GO:0021915 |
160 |
0.079
|
|
|
|
regulation of ion transport
|
GO:0043269 |
215 |
0.078
|
|
|
|
lung induction
|
GO:0060492 |
3 |
0.078
|
|
|
|
glucose import
|
GO:0046323 |
32 |
0.078
|
|
|
|
nucleoside triphosphate catabolic process
|
GO:0009143 |
205 |
0.078
|
|
|
|
cervix development
|
GO:0060067 |
2 |
0.077
|
|
|
|
phenol containing compound metabolic process
|
GO:0018958 |
60 |
0.076
|
|
|
|
negative regulation of vasculature development
|
GO:1901343 |
26 |
0.076
|
|
|
|
chorio allantoic fusion
|
GO:0060710 |
8 |
0.076
|
|
|
|
regulation of epithelial cell proliferation
|
GO:0050678 |
141 |
0.076
|
|
|
|
nucleoside catabolic process
|
GO:0009164 |
206 |
0.075
|
|
|
|
regulation of neural precursor cell proliferation
|
GO:2000177 |
70 |
0.075
|
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
230 |
0.075
|
|
|
|
epinephrine transport
|
GO:0048241 |
1 |
0.075
|
|
|
|
cerebellum morphogenesis
|
GO:0021587 |
42 |
0.074
|
|
|
|
positive regulation of transferase activity
|
GO:0051347 |
167 |
0.074
|
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
222 |
0.074
|
|
|
|
positive regulation of glycolytic process
|
GO:0045821 |
4 |
0.074
|
|
|
|
branching morphogenesis of an epithelial tube
|
GO:0048754 |
159 |
0.073
|
|
|
|
positive regulation of homeostatic process
|
GO:0032846 |
64 |
0.072
|
|
|
|
glomerular epithelial cell development
|
GO:0072310 |
6 |
0.072
|
|
|
|
myotube differentiation
|
GO:0014902 |
105 |
0.072
|
|
|
|
rhombomere 5 formation
|
GO:0021666 |
1 |
0.072
|
|
|
|
proximal convoluted tubule development
|
GO:0072019 |
1 |
0.072
|
|
|
|
cardiac muscle tissue morphogenesis
|
GO:0055008 |
44 |
0.072
|
|
|
|
establishment or maintenance of epithelial cell apical basal polarity
|
GO:0045197 |
14 |
0.072
|
|
|
|
response to fructose
|
GO:0009750 |
2 |
0.072
|
|
|
|
lung vasculature development
|
GO:0060426 |
7 |
0.072
|
|
|
|
organophosphate catabolic process
|
GO:0046434 |
232 |
0.072
|
|
|
|
purine containing compound biosynthetic process
|
GO:0072522 |
70 |
0.071
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.071
|
|
|
|
negative regulation of canonical wnt signaling pathway
|
GO:0090090 |
51 |
0.071
|
|
|
|
regulation of synaptic plasticity
|
GO:0048167 |
87 |
0.071
|
|
|
|
skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration
|
GO:0014834 |
3 |
0.071
|
|
|
|
metanephric tubule development
|
GO:0072170 |
18 |
0.071
|
|
|
|
grooming behavior
|
GO:0007625 |
16 |
0.071
|
|
|
|
cellular response to organic cyclic compound
|
GO:0071407 |
87 |
0.071
|
|
|
|
positive regulation of bmp signaling pathway
|
GO:0030513 |
23 |
0.071
|
|
|
|
facial nerve structural organization
|
GO:0021612 |
10 |
0.071
|
|
